Tenaya Therapeutics, Inc.
TNYA
Revenue
0.00
0.000.00%
-Assets
163.19M
▼-21.71M▼-11.74%
3 Months ChangeLiabilities
29.19M
▲2.47M▲9.24%
3 Months ChangeFree Cash Flow
-29.22M
▲1.70M▲5.48%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-16
Form 8-K
ID: 0000950170-24-106817
2024-08-08
Form 10-Q
ID: 0000950170-24-094059
2024-08-08
Form 8-K
ID: 0000950170-24-093991
2024-07-25
Form 8-K
ID: 0001193125-24-184817
2024-06-27
Form 8-K
ID: 0000950170-24-078585
2024-05-31
Form 8-K
ID: 0000950170-24-067318
2024-05-14
Form 10-Q
ID: 0000950170-24-059576
2024-05-14
Form 8-K
ID: 0000950170-24-059539
2024-03-18
Form 8-K
ID: 0000950170-24-032826
2024-02-08
Form 8-K
ID: 0001193125-24-027611